Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1985 Jul;28(1):37–40. doi: 10.1128/aac.28.1.37

In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam.

P Van der Auwera, B Scorneaux
PMCID: PMC176305  PMID: 2994557

Abstract

The in vitro susceptibility of human isolates of Campylobacter jejuni was investigated with 27 antibiotics and 8 combinations of beta-lactams with clavulanic acid or sulbactam. Ansamycin, the new quinolines, erythromycin, and cefpirome were the most active drugs against C. jejuni; amoxicillin, ampicillin, cefotaxime, and ceftazidime 90% of the isolates, greater than or equal to 50 mg/liter). The activity of various beta-lactams was unchanged by the addition of clavulanic acid or sulbactam.

Full text

PDF
37

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam D., de Visser I., Koeppe P. Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination. Antimicrob Agents Chemother. 1982 Sep;22(3):353–357. doi: 10.1128/aac.22.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blaser M. J., Hoverson D., Ely I. G., Duncan D. J., Wang W. L., Brown W. R. Studies of Campylobacter jejuni in patients with inflammatory bowel disease. Gastroenterology. 1984 Jan;86(1):33–38. [PubMed] [Google Scholar]
  3. Bornside G. H., Cohn I., Jr Intestinal antisepsis. Stability of fecal flora during mechanical cleansing. Gastroenterology. 1969 Nov;57(5):569–573. [PubMed] [Google Scholar]
  4. Brumfitt W., Franklin I., Grady D., Hamilton-Miller J. M., Iliffe A. Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother. 1984 Nov;26(5):757–761. doi: 10.1128/aac.26.5.757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carlson J. R., Thornton S. A., DuPont H. L., West A. H., Mathewson J. J. Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens. Antimicrob Agents Chemother. 1983 Oct;24(4):509–513. doi: 10.1128/aac.24.4.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cavanagh P., Ryden A. Campylobacters isolated from hospital patients. Med J Aust. 1978 Oct 21;2(9):435–435. doi: 10.5694/j.1326-5377.1978.tb76837.x. [DOI] [PubMed] [Google Scholar]
  7. Cofsky R. D., duBouchet L., Landesman S. H. Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers. Antimicrob Agents Chemother. 1984 Jul;26(1):110–111. doi: 10.1128/aac.26.1.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Conly J. M., Ramotar K., Chubb H., Bow E. J., Louie T. J. Hypoprothrombinemia in febrile, neutropenic patients with cancer: association with antimicrobial suppression of intestinal microflora. J Infect Dis. 1984 Aug;150(2):202–212. doi: 10.1093/infdis/150.2.202. [DOI] [PubMed] [Google Scholar]
  9. Della Bruna C., Schioppacassi G., Ungheri D., Jabès D., Morvillo E., Sanfilippo A. LM 427, a new spiropiperidylrifamycin: in vitro and in vivo studies. J Antibiot (Tokyo) 1983 Nov;36(11):1502–1506. doi: 10.7164/antibiotics.36.1502. [DOI] [PubMed] [Google Scholar]
  10. Dicarlo F. J., Crw M. C., Melgar M. D., Roemer S., Ringel S. M., Haynes L. J., Wilson M. Oxolinic acid metabolism by man. Arch Int Pharmacodyn Ther. 1968 Aug;174(2):413–427. [PubMed] [Google Scholar]
  11. DuPont H. L., Reves R. R., Galindo E., Sullivan P. S., Wood L. V., Mendiola J. G. Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone. N Engl J Med. 1982 Sep 30;307(14):841–844. doi: 10.1056/NEJM198209303071401. [DOI] [PubMed] [Google Scholar]
  12. Kager L., Liljeqvist L., Malmborg A. S., Nord C. E., Pieper R. Effects of ampicillin plus sulbactam on bowel flora in patients undergoing colorectal surgery. Antimicrob Agents Chemother. 1982 Aug;22(2):208–212. doi: 10.1128/aac.22.2.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Muytjens H. L., van Veldhuizen G. L., Welling G. W., van der Ros-van de Repe J., Boerema H. B., van der Waaij D. Selective decontamination of the digestive tract by pipemidic acid. Antimicrob Agents Chemother. 1983 Dec;24(6):902–904. doi: 10.1128/aac.24.6.902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nelson J. D., Kusmiesz H., Jackson L. H., Woodman E. Trimethoprim-sulfamethoxazole therapy for shigellosis. JAMA. 1976 Mar 22;235(12):1239–1243. [PubMed] [Google Scholar]
  15. Pai C. H., Gillis F., Tuomanen E., Marks M. I. Erythromycin in treatment of Campylobacter enteritis in children. Am J Dis Child. 1983 Mar;137(3):286–288. doi: 10.1001/archpedi.1983.02140290072019. [DOI] [PubMed] [Google Scholar]
  16. Pepersack F., Prigogyne T., Butzler J. P., Yourassowsky E. Campylobacter jejuni post-transfusional septicaemia. Lancet. 1979 Oct 27;2(8148):911–911. doi: 10.1016/s0140-6736(79)92738-7. [DOI] [PubMed] [Google Scholar]
  17. Pitkanen T., Pettersson T., Pomka A., Kosunen T. U. Effect of erythromycin on the fecal excretion of Campylobacter fetus subspecies jejuni. J Infect Dis. 1982 Jan;145(1):128–128. doi: 10.1093/infdis/145.1.128. [DOI] [PubMed] [Google Scholar]
  18. Rettig P. J. Campylobacter infections in human beings. J Pediatr. 1979 Jun;94(6):855–864. doi: 10.1016/s0022-3476(79)80202-4. [DOI] [PubMed] [Google Scholar]
  19. Vanhoof R., Vanderlinden M. P., Dierickx R., Lauwers S., Yourassowsky E., Butzler J. P. Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents. Antimicrob Agents Chemother. 1978 Oct;14(4):553–556. doi: 10.1128/aac.14.4.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Walder M. Susceptibility of Campylobacter fetus subsp. jejuni to twenty antimicrobiol agents. Antimicrob Agents Chemother. 1979 Jul;16(1):37–39. doi: 10.1128/aac.16.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wells C. L., Podzorski R. P., Peterson P. K., Ramsay N. K., Simmons R. L., Rhame F. S. Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients. J Infect Dis. 1984 Nov;150(5):699–706. doi: 10.1093/infdis/150.5.699. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES